LY2584702
| CAS No. | 1082949-67-4 | Cat. No. | BCP14038 |
| Name | LY2584702 | ||
| Synonyms | LY 2584702;LY-2584702; LYS6K2; LYS-6K2; LYS 6K2; | ||
| Formula | C21H19F4N7 | M. Wt | 445.42 |
| Description | LY-2584702 is an orally available inhibitor of p70S6K signaling, with potential antineoplastic activity. LY2584702 inhibits ribosomal protein S6 Kinase (p70S6K), and prevents phosphorylation of the S6 subunit of ribosomes, thereby inhibiting normal ribosomal function within tumor cells leading to a decrease in protein synthesis and in cellular proliferation. P70S6K, a serine/threonine kinase, acts downstream of PIP3 and phosphoinositide-dependent kinase-1 in the PI3 kinase pathway, is often upregulated in a variety of cancer cells, and is involved in the regulation of cell growth, proliferation, motility, and survival. | ||
| Pathways | PI3K/Akt/mTOR MAPK Pathway | ||
| Targets | RSK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.